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Abstract
Currently, the potential for cardiovascular (CV) stress-induced risk is primarily based on the theoretical (obvious) side effects of
stress on the CV system. Salivary cortisol and a-amylase, produced respectively by the hypothalamus-pituitary-adrenal (HPA)
axis and the sympathetic-adrenomedullary (SAM) system during stress response, are still not included in the routine evaluation
of CV risk and require additional and definitive validation. Therefore, this article overviews studies published between 2010 and
2015, in which salivary cortisol and a-amylase were measured as stress biomarkers to examine their associations with CV/CMR
(cardiometabolic risk) clinical and subclinical indicators. A comprehensive search of PubMed, Web of Science and Scopus
electronic databases was performed, and 54 key articles related to the use of salivary cortisol and a-amylase as subclinical
indicators of stress and CV/CMR factors, including studies that emphasized methodological biases that could influence the
accuracy of study outcomes, were ultimately identified. Overall, the biological impact of stress measured by salivary cortisol and
a-amylase was associated with CV/CMR factors. Results supported the use of salivary cortisol and a-amylase as potential
diagnostic tools for detecting stress-induced cardiac diseases and especially to describe the mechanisms by which stress
potentially contributes to the pathogenesis and outcomes of CV diseases.
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Introduction
Cardiometabolic risk (CMR) refers to risk factors that
increase the likelihood of experiencing vascular events
or of developing metabolic disease (1,2). In addition to
traditional cardiovascular (CV) risk factors (age, gender,
family history, hypertension, dysglycemia, dyslipidemia,
and smoking), CMR factors include abdominal obesity,
insulin resistance, inflammation, lack of consumption of
fruits and vegetables, sedentary lifestyle, and especially
stress, an important component of modern life that has
become a significant health problem in the general popu-
lation (3,4).
Currently, we use the word ‘‘stress’’ to describe the
feeling of being overwhelmed by the psychophysical stress-
induced challenges of daily life; this feeling may be highly
adaptive from an evolutionary point of view because it
allows us to cope with similar circumstances in the future.
For the sake of brevity and to avoid delving too far into the
details of the evolution of the concept of stress that has
occurred over the past few centuries, we will refer to the
modern and very comprehensive proposal that was put
forth by Bruce McEwen to explain the complexity of the
stress response (5–8). This proposal can be synthesized by
the expressions ‘‘to be stressed’’ and ‘‘to be stressed out’’,
which distinguish good stress challenges from bad stress
challenges. According to McEwen’s proposal, the patho-
physiology of the stress response can be described by the
concept of allostasis, which is the process of achieving
stability (or homeostasis) through physiological or beha-
vioral change. Allodynamic processes can be adaptive in
the short term (allostasis) and maladaptive in the long term
(allostatic load). The identity of the factors that determine
the threshold between adaptive and maladaptive responses
to stressors remains an open question for researchers in
the field of stress. This question highlights the need to
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search for predictive biomarkers of the risk of developing
stress-related diseases.
Activation of the hypothalamic-pituitary-adrenal (HPA)
axis and sympathetic adrenomedullary (SAM) system is
essentially an adaptive mechanism that enables the
human body to maintain physiological stability in response
to general stress signals. Complex reciprocal counter-
balances between the HPA axis and SAM system have
been described, and stress-induced chronic stimulation
and dysregulation of these systems may cause metabolic
abnormalities (8–13).
Substantial evidence indicates that chronic elevation
of cortisol levels and dysfunction of the feedback system
within the HPA axis play a prominent role in stress respons-
es (14,15). However, the opposite has also been clearly
shown as the hyporesponsive HPA axis has been linked to
increased susceptibility to chronic illness (16–18).
Salivary levels of free cortisol are characterized by
circadian fluctuation; concentrations in the morning are
significantly higher than those in the evening. The cortisol
awakening response (CAR) refers to the typical produc-
tion of cortisol that occurs upon awakening. As part of a
cycle within a cycle, the CAR reflects the changes in
cortisol concentration that occur during the first hour after
waking from sleep in the morning (11,18–21).
Activation of the SAM system may induce pathophy-
siological changes in cardiovascular activity that range
from a mere increase in heart rate (HR), blood pressure
(BP) and free fatty acids in healthy subjects to the induc-
tion of angina, myocardial infarction, ventricular arrhyth-
mia and acute heart failure in patients with significant
coronary lesions (22,23). The search for a ‘‘cortisol-like’’
non-invasive and easily obtainable marker of SAM acti-
vation led to the identification of salivary a-amylase as a
promising candidate because its secretion is under strong
neurohormonal control (24–26).
Currently, the potential for CV stress-induced risk is
primarily based on the theoretical (obvious) side effects of
stress on the cardiovascular system. Furthermore, while
CV/CMR factors are routinely assessed in clinical practice,
saliva-based biomarkers produced by HPA axis/SAM
system (dys)function during stress response are still not
included in the routine evaluation of cardiovascular risk and
require additional and definitive validation. Therefore, this
article overviews studies published between 2010 and 2015
related to the use of salivary cortisol and a-amylase as
subclinical indicators of stress, and as CV/CMR factors,
including studies that emphasized methodological biases
that could influence the accuracy of study outcomes.
Material and Methods
Eligible studies were original research articles pub-
lished in peer-reviewed journals between January 2010
and December 2015 and identified through searches of
the PubMed, Web of Science and Scopus electronic
databases (27). We included studies if they involved
human subjects in which salivary cortisol and a-amylase
were measured as stress biomarkers to examine the
associations with CV/CMR clinical and subclinical indica-
tors. The term ‘‘cardiometabolic risk (factor)’’ was paired
with ‘‘stress’’, ‘‘psychological stress’’, ‘‘stress hormones’’,
‘‘salivary cortisol’’, ‘‘salivary a-amylase’’, ‘‘hypothalamus-
pituitary-adrenal (HPA) axis ’’, and ‘‘sympathetic adreno-
medullary (SAM) system’’. A flow chart describing the
process of study identification is shown in Figure 1. During
Skype conferences, all coauthors did the search through
repeated use of the words in different combinations. Studies
were included only if they assessed stress-induced re-
sponse either to laboratory challenges, psychosocial items
and/or diseases in different populations by measuring sali-
vary cortisol and/or salivary a-amylase as well as clinical/
subclinical indicators of CV/CMR.
The initial search yielded 569 titles. In addition,
30 supplementary titles were included by scanning the
reference lists of retrieved papers. All abstracts were
independently read by each coauthor: 408 non-human
studies, reviews, letters, editorials, and non-English lan-
guage reports were excluded. From the remaining 191
abstracts, all full manuscripts were gathered and were
independently reviewed by each coauthor for key informa-
tion. One hundred and thirty-seven studies were excluded
because they were not relevant to the purpose of the review,
since: a) they did not report salivary cortisol and/or a-amylase
assessment, or b) because they evaluated stress response
through psychometric tools only, or c) they considered
the occurrence of stressful events itself as a CV/CMR
factor without any salivary stress biomarker assessment.
All coauthors independently assessed eligibility by
reviewing full text articles; if any coauthor was unsure
whether an article met eligibility criteria, the article was
discussed among the research team and full agreement
was always reached. As shown in the flow chart of the
literature selection process (Figure 1), 54 key articles were
ultimately identified to be reviewed in this paper. Among
these key articles, 46 were related to the stress-induced
modification of the HPA axis and SAM system associ-
ated with variation in subclinical and clinical indicators
of CV/CMR, and 8 addressed crucial methodological
issues.
Results
Supplementary Table S1 includes stressor, CV/CMR
subclinical and clinical indicators, salivary biomarker
measured, and a summary of the outcomes for each
selected study. Sources of stress varied across studies.
Stressors included mental task challenges, job strain
and work shift, sport competition, effort test, ambulatory
surgical stress, hypobaric hypoxia, and hypoxia and
sleep fragmentation induced by obstructive sleep apnea
in obese subjects.
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Researchers studied salivary cortisol (11,28,30–34,
37–40,42–47,49–54,56–68,70,71) and/or salivary a-amylase
response to stress (11,29,32,33,35,36,40–42,44,48,49,
52,53,55,59,61,63,66,69–72) for their association with
CV/CM items. A substantial number of these studies
showed significant correlations between salivary cor-
tisol and/or salivary a-amylase and clinical/subclinical
CV/CMR indicators (28,29,31,32,36,37,44,50,55). Several
studies have demonstrated the association between
stress-induced salivary cortisol and/or salivary a-amylase
modifications and CV/CMR clinical/subclinical indicators
(11,35,47,70,71).
Numerous methodological factors (biological and
procedural/analytical) can influence saliva-based human
neuro-endocrine measurements and, consequently, can
dramatically compromise the accuracy and validity of
research.
Table 1 lists studies providing an overview of the metho-
dological recommendations that must be considered to
prevent the danger of obtaining biased results when
Figure 1. Literature selection method.
Table 1. Selected studies concerning methodological aspects of salivary stress biomarker assessment.
Author, Year Saliva-based stress biomarkers Methodological recommendation
Bosch et al. (25) 2011 a-Amylase Salivary flow rate contribution
Ghiciuc et al. (20) 2011 Cortisol & a-Amylase Adherence to salivary collection protocol
Hall et al. (73) 2012 Cortisol Adherence to salivary collection protocol
Inder et al. (74) 2012 Cortisol Laboratory assessment techniques
Sanchez et al. (75) 2012 Cortisol Mathematical/statistical methods applied to salivary
stress biomarker assessment
Nater et al. (76) 2013 Cortisol & a-Amylase Adherence to salivary collection protocol
Russell et al. (77) 2015 Cortisol Inter-laboratory round-robin standardization
Stalder et al. (78) 2016 Cortisol General guidelines for the assessment of salivary biomarkers
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assessing salivary cortisol and/or salivary a-amylase as
stress biomarkers. For example, nonadherence to the
saliva collection protocol or invisible traces of blood can
interfere with the results of saliva testing (78). Ecological
momentary assessment studies provide reproducible and
reliable evaluation of stress biomarkers that can be even
improved through multiple sampling (20,73,76,78) and
that, in contrast to blood sampling, can be easily achieved
through saliva-based testing strategy. However, food intake
should be restricted to 1–2 h prior to saliva sampling. Water
intake does not affect test results, although coffee/alcohol
and other drinks are not recommended (78). In addition, all
other factors that influence salivary flow rate must be taken
into account especially when salivary a-amylase is assayed
as a non-invasive marker for SAM system activity (25).
Other efforts to reduce bias include the development of
specific and standardized analytical tools (74), the estab-
lishment of defined reference intervals, and the implemen-
tation of round-robin trials (75–77). However, the lack of
compliance that sometimes occurs with outpatient saliva
donors requires strict standardization of both collection and
analysis methods to improve the possibility of comparing
salivary biomarker data (20,73,76,78).
Discussion
The purpose of this study was to provide a literature
overview regarding the use of saliva-based stress biomark-
ers to explore the association of stress with CV/CMR
indicators. Physiological stress response also includes a
general arousal component that is associated with reactivity
of the HPA axis/SAM system and is respectively measur-
able via salivary cortisol and via autonomic nervous system
indices such as salivary a-amylase.
Articles have reported and discussed individual sali-
vary cortisol and/or a-amylase differences in response to
acute stress challenge (laboratory stress, i.e., under con-
trolled conditions) that may be useful to underlie some of
the subjective differences in CV/CM stress-induced vulner-
abilities in healthy populations as well as in people with
advanced CV/CM diseases (28,50,64). We have also
reported studies supporting the connection between
stress-induced allostatic (over)load and the appearance
of more or less severe CV/CM disorders (37,47,50,51,53,
56,57,64,65).
We found that the biological impact of stress measured
by salivary cortisol and a-amylase was associated with
CV/CMR factors. Taken together, the studies included in
the present literature review suggest that changes in
salivary cortisol and a-amylase concentrations, as well as
their diurnal fluctuations, may have general implications for
providing further biological mechanisms by which stress
(overload) can be considered itself as a CV/CMR factor.
In agreement with previous speculations that HPA
axis/SAM system dysfunction can potentially result in
CV/CM diseases (79–82), the reports included in this
review showed that several patterns of (acute/chronic)
stress-induced production of salivary cortisol and/or
salivary a-amylase are associated with abnormal HPA
axis and SAM system activities, often concomitant with an
unhealthy lifestyle, and potentially having detrimental
effects on the CV system.
Monitoring activities of the SAM system and HPA axis
is particularly important for the study of adaptive mechan-
isms of the autonomic and HPA stress resilience (32).
Salivary free cortisol is a well-known marker of HPA
axis activity and plays a crucial role in an organism’s
efforts to respond/adapt to stressors (15). The major
advantage of salivary a-amylase measurements over other
parameters that reflect SAM system activity (i.e., CV activity
measures or skin conductance) is that it is measured in
saliva and therefore allows ecological momentary assess-
ments.
Although saliva has not yet become a common sample
source for the analysis of saliva-based stress biomarkers,
this evolving field of research represents a reliable method
of investigating HPA axis and SAM activity, providing a
means to avoid the stressful event of venipuncture and
offering the possibility of self-collection by subjects.
Previous studies from other groups as well as from our
own have shown that the collection of saliva provides a
noninvasive, stress-free, reliable source for monitoring the
human body’s stress response, even in real life context, in
different pathophysiological conditions without requiring
the assistance of medical staff. Since 1983 (84) and
thereafter, salivary cortisol concentration was found to be
directly proportional to the serum unbound cortisol con-
centration both in normal men and women and in women
with elevated cortisol-binding globulin. The correlation
was excellent in dynamic tests of adrenal function (dexa-
methasone suppression, ACTH stimulation), in healthy
subjects and in patients with adrenal insufficiency, in tests
of circadian variation and in randomly collected samples.
Women in the third trimester of normal pregnancy exhib-
ited elevated salivary cortisol throughout the day. The
rate of equilibrium of cortisol between blood and saliva
was very fast, being less than 5 minutes. Since only free
levels of cortisol are detected in saliva, salivary cortisol is
suggested to be a more appropriate measure for the
clinical assessment of adrenocortical function than serum
cortisol (11,18,20,25,26,37,67,70,74,76,83–85).
Regarding salivary a-amylase, this biomarker is
measured exclusively in saliva. During recent years, a
growing interest emerged in using salivary a-amylase as a
non-invasive, surrogate marker for sympathetic activity.
Salivary a-amylase has been proposed as a sensitive
biomarker for stress-related changes in the body that
reflect the activity of the sympathetic nervous system, and
a growing body of research is accumulating to support the
validity and reliability of this parameter. Numerous studies
applying stress protocols have demonstrated that salivary
a-amylase is highly sensitive to stress-related changes.
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This field of research is still in its early stages. However,
the studies included in our review further support the
evidence that the employment of salivary a-amylase as an
indicator of the SAM system (dys)-regulation is promising.
Nevertheless, considerable long-term effort is still required
for this approach to receive acceptance, especially by
clinicians. Thus, actions to improve reliability can assist
researchers in reducing measurement outcome variance
of saliva-based stress biomarkers assessment and increase
the validity of provided pathophysiological data, contribut-
ing to improving the interpretation and understanding of
study results.
The main message of this overview is in support of
the use of saliva-based stress biomarker assessment,
not only in research but also in clinical practice. Indeed,
in our literature review, we did not identify a single clear
objection to the use of saliva as a diagnostic fluid,
although we did identify strict methodological recom-
mendations to avoid factors that influence and add
variance to saliva-based stress biomarker measurement
outcomes.
Stress-induced symptoms are malleable; they can
affect different body systems and overlap between one
type of disorder and another. Therefore, stress manage-
ment strategies are frequently complex and need to be
matched to the requirements of individual patients, begin-
ning with the presumably positive diagnosis of a stress-
induced disorder and continuing through rehabilitation
and training to cope with distress. The use of validated
saliva-based biomarkers as indicators of stress-induced
body system vulnerability (allostatic overload) could support
patients in improving their strategies to cope with challeng-
ing life events, through non-pharmacological approaches
(11,58,86–88).
Supplementary Material
Click here to view [pdf].
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